Board of Directors

Felix (Fangyong) Du, Ph.D.

Felix (Fangyong) Du, Ph.D.

Director

Felix (Fangyong) Du, Ph.D., Chief Technology Officer of Adagene, has served as our director since April 2023. Dr. Du has over 20 years of experience in biological research and discovery, and has published numerous peer-reviewed articles in world-renowned scientific journals such as Nature and Science. His discoveries were featured on the cover of Nature and critically reviewed with high praise by prominent scientists in the field.

Before joining Adagene, Dr. Du worked at Affomix, a biotech startup by Yale professors that specializes in high throughput discovery of antibodies against human proteome. He created an innovative technology platform for high throughput preparation and oriented presentation of antigens. After Affomix was acquired by Illumina Inc., Dr. Du continued to develop new technologies in protein and nucleic acid chemistry.

Dr. Du completed his postdoctoral research with Dr. Jorge Galan at Yale University, received his Ph.D. under the guidance of Dr. Alex Varshavsky at the California Institute of Technology, and obtained his B.S. and M.S. from Peking University.

Board of Directors